Afuco™ Anti-Human BLAA B7 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-BLAA B7 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that immunospecifically bind to a BLAA polypeptide are used for treating diseases associated with immune-response disorders.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-065CL |
Pricing | Inquiry |
Host | Humanized |
Target | BLAA B7 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | Store at -20°C. Open under aseptic conditions. |